Newlife to develop wristwatch heart rate monitor:
This article was originally published in Clinica
Executive Summary
US company Newlife Technologies is to use technology licensed from BTG International to develop a wristwatch-like device that can noninvasively monitor vital signs in the human body, such as heart rate. The technology consists of an optical fibre sensor that can pick up physiological changes in the body through the strap, Steve Burton, Newlife's president told Clinica. The Midlothian, Virginia-based company will use the technology to enhance its FDA-approved heart rate monitoring product, the HEARTalker, which vocally feeds back ECG measurements from a strap worn around the chest to assist the user during personal training.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.